Anavex Life Sciences Corp (AVXL)

[nidan7500]

Finally, most of the flat earth people have declared "Das Ende"...done, we give up, it don't work, let's all just move on...after a long time and much discussion they agree. And, IMO, they have declared an end to whatever scientific method got this result....I hope. But, I do expect there will still be people who insist that(even if it does not work you MUST have thousands of people in meaningless trials to prove it, b/c I cannot change my mental model on trials...)....NAH, NA ,NA, NAH NAHHH,....GOOD BYE..

The results come just days after pharmaceutical giant Pfizer announced it was ending research into treatments for Alzheimer’s and Parkinson’s disease, and redirecting funding into other areas.
Dr James Pickett, Head of Research at Alzheimer’s Society, said that the failure of idalopirdine to improve cognition in those with Alzheimer’s was disappointing.

MAYBE NOW..(another example of failed protocol).the FDA feels safe to come out of the closet and define a process that works...we all had to wait for the ESTABLISHMENT to admit it was OK TO MOVE ON.
...We'll see, any day now.

Blood plasma infusions from young may arrest Alzheimer’s
Read more

“News from last year showed that a drug that worked in a similar way, intepirdine, also did not have any benefit. These results indicate that this type of drug may not have the effects we were hoping for in people with Alzheimer’s, and we need to broaden our focus,” he said, adding that he remained hopeful that research would uncover new treatments, despite the recent move from Pfizer.
“Advances in technology mean that we are starting to see the hallmarks of Alzheimer’s disease in the living brain and researchers can be confident people enrolled in a trial are definitely affected by Alzheimer’s, rather than something with similar symptoms – which may have been one of the problems facing the idalopirdine trial,” he added. “Such a technological breakthrough will be a vast improvement to the way clinical trials into Alzheimer’s are conducted, and provide great hope for finding a new treatment in the future.”

https://www.theguardian.com/society/2018/jan/09/alzheimers-setback-as-promising-drug-shows-no-benefit-in-clinical-trials-idalopirdine